Gemmer Asset Management LLC Glaukos Corp Transaction History

Gemmer Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$34.86 - $63.77 $4,113 - $7,524	-118 Closed	0 $0
Q4 2021 Jan 21, 2022	BUY	$40.27 - $56.99 $2,617 - $3,704	65 Added 122.64%	118 $5,000
Q2 2020 Jul 31, 2020	BUY	$28.78 - $46.83 $115 - $187	4 Added 8.16%	53 $2,000
Q1 2020 May 01, 2020	BUY	$25.53 - $70.14 $1,250 - $3,436	49 New	49 $1,000

303

47M

75.3K

157K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.01B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Gemmer Asset Management LLC with notifications on news.